SKI Market

Indian Indices

Nifty

25,114.00 108.50
(0.43%)

Sensex

81,904.70 355.97
( 0.44%)

Bank Nifty

54,809.30 139.70
( 0.26%)

Nifty IT

36,110.75 107.30
( 0.30%)

Global Indices

Nasdaq

46,125.99 614.06
(1.35%)

Dow Jones

6,607.70 54.66
(0.83%)

Hang Seng

44,778.02 405.52
(0.91%)

Nikkei 225

9,283.29 -14.29
(-0.15%)

Forex

USD-INR

88.10 -0.04
(-0.05%)

EUR-INR

103.12 -0.37
(-0.35%)

GBP-INR

119.23 -0.20
(-0.16%)

JPY-INR

0.60 0.00
(-0.23%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Marksans Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524404

INE750C01026

30.5295026

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

MARKSANS

38.64

7896.38

EPS(TTM)

Face Value()

Div & Yield %

4.51

0.46

Back

Marksans Pharma Ltd - Marksans Pharma Limited - Press Release

Aug 18,2025

Marksans Pharma Limited has informed the Exchange regarding a press release dated August 18, 2025, titled 'Marksans Pharma Limited s wholly owned subsidiary in UK, Relonchem Limited receives Marketing Authorization for its products.'.

25,114.00 108.50 (0.43%)

81,904.70 355.97 ( 0.44%)

54,809.30 139.70 ( 0.26%)

36,110.75 107.30 ( 0.30%)

46,125.99 614.06 (1.35%)

6,607.70 54.66 (0.83%)

44,778.02 405.52 (0.91%)

9,283.29 -14.29 (-0.15%)

88.10 -0.04 (-0.05%)

103.12 -0.37 (-0.35%)

119.23 -0.20 (-0.16%)

0.60 0.00 (-0.23%)